Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period

NCT05135104 · clinicaltrials.gov ↗

UNKNOWN

Status

650

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Palbociclib

Sponsor

Asociatia Oncohelp - Centrul de Oncologie Oncohelp

Collaborators

[object Object]